Although no GLP-1 RA trials have been conducted in youth with T2DM with a primary focus on weight reduction, GLP-1 RAs have been found to promote weight loss in youth with obesity without diabetes (18–20). The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.